Education
About Us
Working with TipRanks
Follow Us
Sundrug Co (SDGCF)
OTHER OTC:SDGCF
Total Valuation
Sundrug Co has a market cap or net worth of $3.76B. The enterprise value is $466.25B.
Market Cap$3.76B
Enterprise Value$466.25B
Share Statistics
Sundrug Co has 119.33M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119.33M
Owned by Insiders
Owned by Instutions
Financial Efficiency
Sundrug Co’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.66%.
Return on Equity (ROE)11.51%
Return on Assets (ROA)6.93%
Return on Invested Capital (ROIC)9.66%
Return on Capital Employed (ROCE)15.49%
Revenue Per Employee$118,492,794.956
Profits Per Employee$4,529,420.594
Employee Count6,662
Asset Turnover1.79
Inventory Turnover6.16
Valuation Ratios
The current PE Ratio of Sundrug Co is 18.69. Sundrug Co’s PEG ratio is 1.41.
PE Ratio18.69
PS Ratio0.72
PB Ratio2.15
Price to Fair Value2.15
Price to FCF183.72
Price to Operating Cash Flow13.22
PEG Ratio1.41
Income Statement
In the last 12 months, Sundrug Co had revenue of $789.40B and earned $30.18B in profits. Earnings per share was $257.99.
Revenue$789.40B
Gross Profit$200.25B
Operating Income$42.60B
Pretax Income$41.93B
Net Income$30.18B
EBITDA54.42B
Earnings Per Share (EPS)257.99
Cash Flow
In the last 12 months, operating cash flow was $8.89B and capital expenditures -$8.32B, giving a free cash flow of $571.00M billion.
Operating Cash Flow$8.89B
Free Cash Flow$571.00M
Free Cash Flow per Share$4.79
Dividends & Yields
Sundrug Co pays an annual dividend of $0.45, resulting in a dividend yield of 2.68%
Dividend Per Share$0.45
Dividend Yield2.68%
Payout Ratio25.19%
Free Cash Flow Yield0.54%
Earnings Yield5.35%
Stock Price Statistics
Beta0.28
52-Week Price Change15.93%
50-Day Moving Average27.84
200-Day Moving Average26.32
Relative Strength Index (RSI)75.99
Average Volume (3m)0.00
Important Dates
Sundrug Co upcoming earnings date is May 9, 2025, TBA.
Last Earnings DateFeb 14, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Sundrug Co as a current ratio of 1.34, with Debt / Equity ratio of 0.14
Current Ratio1.34
Quick Ratio0.75
Debt to Market Cap0.06
Net Debt to EBITDA-0.61
Interest Coverage Ratio1.28K
Taxes
In the past 12 months, Sundrug Co has paid $11.75B in taxes.
Income Tax$11.75B
Effective Tax Rate29.41%
Enterprise Valuation
Sundrug Co EV to EBITDA ratio is 9.02, with an EV/FCF ratio of 172.01.
EV to Sales0.68
EV to EBITDA9.02
EV to Free Cash Flow172.01
EV to Operating Cash Flow12.37
Balance Sheet
Sundrug Co has $60.13B in cash and marketable securities with $33.54B in debt, giving a net cash position of -$26.59B billion.
Cash & Marketable Securities$60.13B
Total Debt$33.54B
Net Cash-$26.59B
Net Cash Per Share-$222.78
Tangible Book Value Per Share$2.09K
Margins
Gross margin is 25.18%, with operating margin of 5.45%, and net profit margin of 3.87%.
Gross Margin25.18%
Operating Margin5.45%
Pretax Margin5.49%
Net Profit Margin3.87%
EBITDA Margin7.52%
EBIT Margin5.49%
Analyst Forecast
The average price target for Sundrug Co is $34.54, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$34.54
Price Target Upside9.93%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast